Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Baqsimi Revenue	-	29.10M
Baqsimi Revenue Growth	-	-95.70%
Basaglar Revenue	626.00M	676.90M
Basaglar Revenue Growth	-7.52%	-7.06%
Humalog Revenue	2.17B	2.32B
Humalog Revenue Growth	-6.74%	39.77%
Humulin Revenue	705.00M	917.10M
Humulin Revenue Growth	-23.13%	7.63%
Jardiance Revenue	3.43B	3.34B
Jardiance Revenue Growth	2.73%	21.72%
Mounjaro Revenue	22.97B	11.54B
Mounjaro Revenue Growth	99.00%	123.51%
Trajenta Revenue	318.00M	353.90M
Trajenta Revenue Growth	-10.14%	-8.53%
Trulicity Revenue	4.28B	5.25B
Trulicity Revenue Growth	-18.61%	-26.35%
Zepbound Revenue	13.54B	4.93B
Zepbound Revenue Growth	174.93%	2701.88%
Other Cardiometabolic Health Revenue	189.00M	187.90M
Other Cardiometabolic Health Revenue Growth	0.58%	31.31%
Cardiometabolic Health Revenue	48.22B	29.52B
Cardiometabolic Health Revenue Growth	63.34%	50.10%
Oncology Revenue	9.38B	8.75B
Oncology Revenue Growth	7.12%	31.45%
Immunology Revenue	5.25B	4.39B
Immunology Revenue Growth	19.44%	15.68%
Neuroscience Revenue	1.39B	1.47B
Neuroscience Revenue Growth	-5.59%	-48.81%
Other Product Revenue	944.00M	903.00M
Other Product Revenue Growth	4.54%	-19.53%
Revenue (Other)	-	400.00K
Revenue (Total)	65.18B	45.04B
Revenue (Total) Growth	44.70%	32.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
US Revenue	43.48B	30.38B
US Revenue Growth	43.15%	39.39%
Europe Revenue	11.56B	6.92B
Europe Revenue Growth	67.01%	12.08%
Japan Revenue	2.13B	1.81B
Japan Revenue Growth	17.47%	8.51%
China Revenue	1.95B	1.66B
China Revenue Growth	17.50%	7.84%
Other Foreign Countries Revenue	6.06B	4.27B
Other Foreign Countries Revenue Growth	41.80%	44.98%
Revenue (Other)	-	400.00K
Revenue (Total)	65.18B	45.04B
Revenue (Total) Growth	44.70%	32.00%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue Change due to Price	-6.00%	5.00%
Revenue Change due to Volume	50.00%	27.00%
Revenue Change due to FX	1.00%	-

Updated Feb 4, 2026. Data Source: Fiscal.ai.